In silicomolecular docking study, synthesis andα-amylase inhibitory activity evaluation of phosphorylated derivatives of purine
- 20 October 2021
- journal article
- research article
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 196 (11) , 1010-1017
Abstract
A series of phosphorylated derivatives of purine were synthesized in good yields (88–95%) by the reaction of 2‐chloro‐4‐{[(9H‐purin‐9‐yl)methoxy]methyl}‐1,3,2-λ5‐dioxaphospholan‐2‐one with various heterocyclic amines. In silico molecular docking study was performed for all the designed compounds to assess their potential ability to inhibit the pancreatic α-amylase enzyme. The compounds (6a–j) with good inhibition toward the target enzyme were prompted for the synthesis. Spectroscopic analyses of all the newly synthesized compounds were performed to confirm their structures. In vitro α-amylase inhibitory activity of the synthesized compounds was also carried out using acarbose as a standard drug. The compounds 2‐[(6‐chloro‐1,3‐benzothiazol‐2‐yl)amino]‐4‐{[(9H‐purin‐9‐yl)methoxy]methyl}‐1,3,2λ5‐dioxaphospholan‐2‐one (6j) (IC50, 94.3 ± 0.5 μg/mL) and 1‐methyl‐6‐[(2‐oxo‐4‐{[(9H‐purin‐9‐yl)methoxy]methyl}‐1,3,2λ5‐dioxaphospholan‐2‐yl)amino]‐1,2,3,4‐tetrahydropyrimidine‐2,4‐dione (6f) (IC50, 99.0 ± 0.4 μg/mL) reported the highest inhibition among the synthesized compounds. All the remaining compounds exhibited good to moderate inhibition with IC50 values in the range of 102.9 ± 0.6 to 233.5 ± 0.6 μg/mL when compared with the standard drug, acarbose (IC50, 50.47 ± 0.28 μg/mL). Graphical AbstractKeywords
This publication has 41 references indexed in Scilit:
- Cryptococcosis as an emerging systemic mycosis in dogsJournal of Veterinary Emergency and Critical Care, 2013
- Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-oneEuropean Journal of Medicinal Chemistry, 2013
- Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetesEuropean Journal of Medicinal Chemistry, 2012
- New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purineEuropean Journal of Medicinal Chemistry, 2011
- Theacrine, a purine alkaloid with anti-inflammatory and analgesic activitiesFitoterapia, 2010
- Antimalarial activity of thiosemicarbazones and purine derived nitrilesBioorganic & Medicinal Chemistry Letters, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Evidence‐Based Critical Evaluation of Glycemic Potential of Cynodon dactylonEvidence-Based Complementary and Alternative Medicine, 2007
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Safety Profile of Acarbose, an α-Glucosidase InhibitorDrugs, 1992